NCT01543191View on ClinicalTrials.gov

A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Cystic Fibrosis

Interventions

DRUG

PUR118

low dose and high dose for 3 doses, BID

Trial Locations (1)

BT9 6AD

Celerion, Belfast

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Celerion

INDUSTRY

lead

Pulmatrix Inc.

INDUSTRY